PEPITE EA4267, FHU INCREASE, Univ. Bourgogne Franche-Comté, F-25030 Besançon, France.
INSERM U1093, Univ. Bourgogne Franche-Comté, F-21000 Dijon, France.
Vascul Pharmacol. 2021 Dec;141:106930. doi: 10.1016/j.vph.2021.106930. Epub 2021 Oct 30.
Little is known on the cerebrovascular BDNF (brain-derived neurotrophic factor)/TrkB (tropomyosin related kinase B) pathway. This study investigated the contribution of endogenous endothelial BDNF to the control of vascular tone of rat middle cerebral artery (MCA) and the capacity of exogenous agonist of TrkB receptors to induce their relaxation. Endothelial cells constitutively expressed both BDNF and activated TrkB receptors. Supporting endothelial BDNF as an autocrine regulator of basal myogenic tone, incubation of MCA with the TrkB antagonist cyclotraxin B induced contraction as observed with incubation in the presence of inhibitors of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) production. Exposure of MCA with the TrkB agonist LM22A-4 that increased expression of TrkB receptors phosphorylated at tyrosine 816 induced relaxation of preconstricted MCA (EC 6.7 × 10 mol/L) as efficiently than acetylcholine (EC 5.3 × 10 mol/L). Finally, endothelium removal, exposure to a TrkB antagonist or to inhibitors of NO and EDHF production prevented the relaxant effect of LM22A-4. In conclusion, our study identified endothelial BDNF as a new autocrine regulator of vascular tone of MCA, thus making the endothelial BDNF/TrkB pathway an attractive target for strategies aiming to improve blood supply to the brain.
关于脑血管 BDNF(脑源性神经营养因子)/TrkB(原肌球蛋白相关激酶 B)通路,目前知之甚少。本研究旨在探讨内源性内皮 BDNF 对大鼠大脑中动脉(MCA)血管张力的控制作用,以及外源性 TrkB 受体激动剂诱导其舒张的能力。内皮细胞持续表达 BDNF 和激活的 TrkB 受体。支持内皮 BDNF 作为基础肌源性张力的自分泌调节剂,用 TrkB 拮抗剂环丝氨酸 B 孵育 MCA 可诱导收缩,这与用一氧化氮(NO)和内皮衍生超极化因子(EDHF)产生抑制剂孵育时观察到的情况相同。用增加酪氨酸 816 磷酸化的 TrkB 受体表达的 TrkB 激动剂 LM22A-4 暴露 MCA 可有效诱导预收缩 MCA(EC 6.7×10-7mol/L)舒张,与乙酰胆碱(EC 5.3×10-7mol/L)一样有效。最后,内皮去除、暴露于 TrkB 拮抗剂或 NO 和 EDHF 产生抑制剂可阻止 LM22A-4 的舒张作用。总之,我们的研究确定了内皮 BDNF 是 MCA 血管张力的新的自分泌调节剂,因此,内皮 BDNF/TrkB 通路成为改善脑血流供应的有吸引力的靶点。